u/jciccare · 89d agono track record yet
FEMY READY FOR THE POWER HOUR PUSH
Femasys received FDA approval for its modular PMA submission pathway for FemBloc, a non-surgical permanent birth control technology. The stock is positioned to move from current 2.65 toward resistance at 3.48 on this approval catalyst.
At post $2.71Now $1.28-52.8% since postedas of Nov 16, 4:55 PM ET
1d+0.7%
3d+9.2%
1w+7.7%
1m-4.4%
3m—
6m—
1y—